ACTA1 and Urinary incontinence: Cell treatment, which was performed in the IAS-targeting incontinence model, showed that histologic augmentation of muscular layers stained for α-SMA and calponin was present two weeks after cell injection compared to one week after cell injection in the hADSc-treated group (Figure 4).